Environmental pharmacology: an emerging science


  • Anuradha T. Deshkar Department of Pharmacology, Dr. Vaishampayan Memorial Government Medical College, Solapur, Maharashtra, India
  • Ujwala P. Gawali Department of Pharmacology, Dr. Vaishampayan Memorial Government Medical College, Solapur, Maharashtra, India
  • Prashant A. Shirure Department of Pharmacology, Dr. Vaishampayan Memorial Government Medical College, Solapur, Maharashtra, India




Environmental pharmacology, Ecopharmacovigilance, Pharmaceutical products


With continuous rapid expansion of the human population there is escalating demand for resources, including human and veterinary pharmaceuticals. This has lead to rapid development of global pharmaceutical industry and with that increase in issues caused by pharmaceutical products. In recent years a great concern has been expressed over the occurrence and persistence of pharmaceutical products in the environment and their potential impact on environment. Owing to this the new branch of science called environmental pharmacology has sprouted. Environmental pharmacology deals with dispersion and impact of pharmaceutical products on environment. Solutions need to be suggested to save this only liveable planet from ill effects of these pharmaceutical products. This has given birth to the science of Ecopharmacovigilance (EPV).


Medhi B, Sewal RK. Ecopharmacovigilance: An issue urgently to be addressed. Indian J Pharmacol. 2012;44:547-9.

Grootheest KV. The dawn of Pharmacovigilance: An historical prospective. Int J Pharm Med. 2003;17:195-200.

Wang J, Hu X. Ecopharmacovigilance: Current state, challenges, and opportunities in china. Indian Journal of Pharmacology. 2014;46(1):13.

Srivastava B, Sinha AK, Gaur S., Gaur S, Palaria U.Ecopharmacovigilance: its importance and challenges. Journal of Biomedical and Pharmaceutical Research. 2014;3(3):81-7.

Revannasiddaiah N, Kumar CA. India's progress towards Ecopharmacovigilance. Journal of Drug Discovery and Therapeutics. 2015;3(31):62-8.

Prakash V, Green RE, Pain DJ, Ranade SP, Saravanan S, Prakash N, et al. Recent changes in populations of resident Gyps vultures in India. J Bombay Nat Hist Soc. 2007;104:129-35.

Jones OA, Lester JN, Voulvoulis N. Medicines: A threat to drinking water? Trends Biotechnol. 2005;23:163-7.

Silva LJG, Lino CM, Meisel L, Barceló D, Pena A. Ecopharmacovigilance. In: Barcelo D, editor. The Handbook of Environmental Chemistry. Germany: Springer-Verlag Berlin and Heidelberg GmbH & Co. KG; 2012:213-242.

Bosun Banjoko. Environmental pharmacology- An Overview (Chapter 5). Pharmacology and Therapeutics, In Tech; 2014.

Wise R. Antimicrobial resistance: Priorities of action. J Antimicrob Chemother. 2002;49:585-6.

Green G. Understanding NSAIDs: from aspirin to COX-2. Clin Cornerstone. 2001;3:50-60.

Joss A, Zabczynski S, Gobel A, Hoffmann B, Loffler D, McArdell CS, et al. Biological degradation of medicines in municipal wastewater treatment: Proposing a classification scheme. Water Res. 2006;40:1686-96.

Celiz MD, Tso J, Aga DS. Pharmaceutical metabolites in the environment: Analytical challenges and ecological risks. Environ Toxicol Chem. 2009;28:2473-84.

Holm G, Snape JR, Murray-Smith R, Talbot J, Taylor D, Sörme P. Implementing ecopharmacovigilance in practice: Challenges and potential opportunities. Drug Saf. 2013;36:533-46.

Kummerer K. Drugs in the environment: emission of drugs, diagnostic aids and desinfectants into wastewater by hospitals in relation to other sources: a review. Chemosphere. 2001:45(6-7):957-69.

Barnes KK, Christenson SC, Kolpin DW, Focazio MJ, Furlong ET, Zaugg SD, et al. Pharmaceuticals and other organic waste water contaminants within a leachate plume downgradient of a municipal landfill. Ground Water Monit Remediat. 2004;24(2):119-26.

Daughton CG, Ruhoy IS. The afterlife of drugs and the role of pharmEcovigilance. Drug Saf. 2008;31:1069-82.

Benotti MJ, Trenholm RA, Vanderford BJ, Holady JC, Stanford BD, Snyder SA. Pharmaceuticals and endocrine disrupting compounds in US drinking water. Environmental science & technology. 2008 Dec 17;43(3):597-603.

Huerta-Fontela M, Galceran MT, Ventura F. Occurrence and removal of pharmaceuticals and hormones through drinking water treatment; Water Research. 2011;45:1432-42.

Barnes KK, Kolpin DW, Furlong ET, Zaugg SD, Meyer MT, Barber LB. A national reconnaissance of pharmaceuticals and other organic wastewater contaminants in the United States: I] groundwater. Sci Total Environ. 2008;402:192-200.

Rattner BA, Whitehead MA, Gasper G, Meteyer CU, Link WA, Taggart MA, et al. Apparent tolerance of turkey vultures (Cathartes aura) to the non-steroidal anti-inflammatory drug diclofenac. Environ Toxicol Chem. 2008;27:2341-5.

Charles PG, Grayson ML. The dearth of new antibiotic development: Why we should be worried and what we can do about it. Med J Aust. 2004;181:549-53.

Lai KM, Scrimshaw MD, Lester JN. The effects of natural and synthetic steroid estrogens in relation to their environmental occurrence. Crit Rev Toxicol. 2002;32:113-32.

Velo G, Moretti U. Ecopharmacovigilance for better health. Drug Saf. 2010;33:963-8.




How to Cite

Deshkar, A. T., Gawali, U. P., & Shirure, P. A. (2018). Environmental pharmacology: an emerging science. International Journal of Basic & Clinical Pharmacology, 7(3), 359–362. https://doi.org/10.18203/2319-2003.ijbcp20180645



Review Articles